北京清华长庚医院子宫内膜异位症推荐专家

简介:

北京清华长庚医院，作为一所大型综合性公立医院，在子宫内膜异位症（endometriosis）等妇科疾病治疗方面具有显著的专业实力。医院秉承“三精医疗”理念，致力于打造现代健康医疗服务体系。在治疗子宫内膜异位症方面，医院拥有一支高水平的医疗团队，运用国内外先进的医疗技术和设备，为患者提供精准、高效、优质的诊疗服务。医院设有专门的妇科病区，开展多项针对子宫内膜异位症的微创手术和综合治疗，为患者带来康复的希望。北京清华长庚医院在子宫内膜异位症（endometriosis）治疗领域，以其精湛的医疗技术、严谨的医疗态度和优质的服务，赢得了患者和社会的广泛赞誉。子宫内膜异位症（endometriosis）是指有活性的内膜细胞种植在子宫内膜以外的位置而形成的一种女性常见妇科疾病。内膜细胞本该生长在子宫腔内,但由于子宫腔通过输卵管与盆腔相通,因此使得内膜细胞可经由输卵管进入盆腔异位生长。，子宫内膜种植,免疫防御功能缺陷,遗传与体质的因素,内分泌功能失调，盆腔，子宫内膜异位症的治疗方案,因病情的轻重,患者的年龄和生育情况而有所不同。如病情较重,或表现为重的痛经,或盆腔检查发现有肯定的内膜异位结节,就必须采取药物或手术治疗，卵巢恶性肿瘤、盆腔炎性肿块和子宫腺肌病，尽量少吃含有雌激素的食物,如大豆、洋葱、黑米、小麦等，B型超声检查,腹腔镜检查,实验室检查，。

true 王晓茜主治医师

三级其他北京清华长庚医院

好评率：100% 接诊量：2 平均响应：-

擅长备孕咨询，原发不孕，继发不孕，胎停育，反复流产，阴道炎，盆腔炎，子宫肌瘤，子宫腺肌症，子宫内膜息肉，阴道不规则出血，宫颈病变，卵巢囊肿，卵巢巧克力囊肿，盆腔子宫内膜异位症

接诊医生：

2024-09-06 11:25:48

科普文章

子宫内膜异位症的类型与卵巢癌风险

以下内容来源于pubmed。

Endometriosis Typology and Ovarian Cancer Risk

Abstract

Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

Design, setting, and participants: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

Exposures: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

Main outcomes and measures: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

Conclusions and relevance: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.